Both in Biotechnology
Creative Medical Technology Holdings vs Silexion Therapeutics
Over the past year CELZ returned −86.6% and SLXN returned −99.5%; their daily moves had a correlation of 0.04.
CELZ −86.6% SLXN −99.5%Growth of $1, one year, split-adjusted
| Metric | CELZ | SLXN |
|---|---|---|
| Price | $0.6902 | $0.1657 |
| Market cap | $5.2M | $2.4M |
| Today | −3.06% | −5.10% |
| 1 month | −31.7% | −33.3% |
| 6 months | −69.0% | −97.4% |
| Year to date | −64.8% | −99.1% |
| 1 year | −85.9% | −99.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,746.8× | — |
| Net cash | $8.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 145.0% | 240.5% |
| Short % of float | 2.2% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).